Does BORTEZOMIB Cause Mantle cell lymphoma? 184 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 184 reports of Mantle cell lymphoma have been filed in association with BORTEZOMIB (bortezomib). This represents 0.4% of all adverse event reports for BORTEZOMIB.
184
Reports of Mantle cell lymphoma with BORTEZOMIB
0.4%
of all BORTEZOMIB reports
20
Deaths
31
Hospitalizations
How Dangerous Is Mantle cell lymphoma From BORTEZOMIB?
Of the 184 reports, 20 (10.9%) resulted in death, 31 (16.8%) required hospitalization, and 4 (2.2%) were considered life-threatening.
Is Mantle cell lymphoma Listed in the Official Label?
Yes, Mantle cell lymphoma is listed as a known adverse reaction in the official FDA drug label for BORTEZOMIB.
What Other Side Effects Does BORTEZOMIB Cause?
Plasma cell myeloma (6,683)
Off label use (4,754)
Neuropathy peripheral (4,067)
Drug ineffective (2,730)
Diarrhoea (2,244)
Thrombocytopenia (2,082)
Death (2,025)
Pneumonia (2,020)
Fatigue (1,757)
Neutropenia (1,530)
What Other Drugs Cause Mantle cell lymphoma?
RITUXIMAB (352)
IBRUTINIB (321)
LENALIDOMIDE (179)
VENETOCLAX (174)
CYCLOPHOSPHAMIDE (120)
CYTARABINE (114)
VINCRISTINE (112)
BENDAMUSTINE (109)
DOXORUBICIN (108)
PREDNISONE (96)
Which BORTEZOMIB Alternatives Have Lower Mantle cell lymphoma Risk?
BORTEZOMIB vs BOSENTAN
BORTEZOMIB vs BOSENTAN\BOSENTAN
BORTEZOMIB vs BOSULIF
BORTEZOMIB vs BOSUTINIB
BORTEZOMIB vs BOTOX